Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
01 March 2023 - 11:00PM
Apellis Pharmaceuticals, Inc., (Nasdaq: APLS), a global
biopharmaceutical company and leader in complement, today announced
that the company will participate in the following March investor
conferences:
- Cowen 43rd Annual Healthcare
Conference: Fireside chat on Wednesday, March 8, 2023, at 9:10 a.m.
ET.
- Oppenheimer’s 33rd Annual Healthcare
Conference: Virtual fireside chat on Monday, March 13, 2023, at
3:20 p.m. ET.
Each conference event will be available via a live webcast from
the “Events and Presentations” page of the “Investors and Media”
section of the company’s website. A replay of the webcasts will be
available for 90 days following the event.
About ApellisApellis Pharmaceuticals, Inc. is a
global biopharmaceutical company that combines courageous science
and compassion to develop life-changing therapies for some of the
most challenging diseases patients face. We ushered in the first
new class of complement medicine in 15 years and now have two
approved medicines targeting C3. These include the first and only
therapy for geographic atrophy, a leading cause of blindness around
the world. With nearly a dozen clinical and pre-clinical programs
underway, we believe we have only begun to unlock the potential of
targeting C3 across many serious diseases. For more information,
please visit http://apellis.com or follow us
on Twitter and LinkedIn.
Investor Contact: Meredith
Kaya meredith.kaya@apellis.com617.599.8178
Apellis Pharmaceuticals (NASDAQ:APLS)
Historical Stock Chart
From Mar 2024 to Mar 2024
Apellis Pharmaceuticals (NASDAQ:APLS)
Historical Stock Chart
From Mar 2023 to Mar 2024